These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1786702)

  • 41. Loxiglumide inhibits cholecystokinin stimulated somatostatin secretion and simultaneously enhances gastric acid secretion in humans.
    Verhulst ML; Gielkens HA; Hopman WP; van Schaik A; Tangerman A; Rovati LC; Jansen JB
    Regul Pept; 1994 Oct; 53(3):185-93. PubMed ID: 7846294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A physiological role for cholecystokinin as a regulator of gastrin secretion.
    Beglinger C; Hildebrand P; Meier R; Bauerfeind P; Hasslocher H; Urscheler N; Delco F; Eberle A; Gyr K
    Gastroenterology; 1992 Aug; 103(2):490-5. PubMed ID: 1634067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of a cholecystokinin antagonist, proglumide, on cholecystokinin-8-induced gallbladder contraction in conscious dogs.
    Fujimura M; Sakamoto T; Lluis F; Beauchamp RD; Townsend CM; Greeley GH; Thompson JC
    Biol Signals; 1992; 1(2):94-100. PubMed ID: 1307918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholecystokinin in the regulation of gastric acid and endocrine pancreatic secretion in humans.
    Konturek JW; Stoll R; Gutwinska-Konturek M; Konturek SJ; Domschke W
    Scand J Gastroenterol; 1993 May; 28(5):401-7. PubMed ID: 8511500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of calcitonin-induced growth hormone (GH) suppression: roles of somatostatin and GH-releasing factor.
    Lengyel AM; Tannenbaum GS
    Endocrinology; 1987 Apr; 120(4):1377-83. PubMed ID: 2881773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans.
    Konturek SJ; Kwiecien N; Obtulowicz W; Kopp B; Oleksy J; Rovati L
    Digestion; 1990; 45(1):1-8. PubMed ID: 2340960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide.
    Tanimoto K; Tamminga CA; Chase TN; Nilaver G
    Endocrinology; 1987 Jul; 121(1):127-32. PubMed ID: 3297634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.
    Konturek JW; Konturek SJ; Kurek A; Bogdal J; Oleksy J; Rovati L
    Gut; 1989 Aug; 30(8):1136-42. PubMed ID: 2767511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
    Katsuura G; Hsiao S; Itoh S
    Peptides; 1984; 5(3):529-34. PubMed ID: 6089145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man.
    Jansen JB; Jebbink MC; Douglas BR; Lamers CB
    Eur J Clin Pharmacol; 1990; 38(4):367-70. PubMed ID: 2344859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients.
    Konturek JW; Thor P; Maczka M; Stoll R; Domschke W; Konturek SJ
    Scand J Gastroenterol; 1994 Jul; 29(7):583-90. PubMed ID: 7939393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CCK-resistance in Zucker obese versus lean rats.
    Niederau C; Meereis-Schwanke K; Klonowski-Stumpe H; Herberg L
    Regul Pept; 1997 Jun; 70(2-3):97-104. PubMed ID: 9272621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of cholecystokinin-receptor blockade on pancreatic and biliary function in healthy volunteers.
    Schwarzendrube J; Niederau M; Lüthen R; Niederau C
    Gastroenterology; 1991 Jun; 100(6):1683-90. PubMed ID: 2019374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of unilateral intracerebroventricular microinjections of cholecystokinin (CCK) on circling behavior of rats.
    Morency MA; Ross GM; Hesketh D; Mishra RK
    Peptides; 1987; 8(6):989-95. PubMed ID: 3441450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determination of plasma cholecystokinin (CCK) concentrations by bioassay and radioimmunoassay in man. A critical evaluation.
    Höcker M; Schmidt WE; Creutzfeldt W; Choudhury AR; Nustede R; Schafmayer A; Fölsch UR
    Regul Pept; 1992 Feb; 37(3):255-69. PubMed ID: 1557514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on gastric motility in duodenal ulcer patients.
    Konturek JW; Stoll R; Menzel J; Konturek M; Konturek SJ; Domschke W
    Scand J Gastroenterol; 2001 Mar; 36(3):241-6. PubMed ID: 11305509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apneic effects of cholecystokinin in unanaesthetized fetal sheep.
    Bennet L; Johnston BM; Gluckman PD
    J Dev Physiol; 1990 Oct; 14(4):229-33. PubMed ID: 2099380
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves.
    Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Drozdowicz D; Kwiecień S; Hahn EG
    Regul Pept; 1999 Jun; 82(1-3):19-33. PubMed ID: 10458643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On the fate of centrally administered somatostatin in the rat: massive hypersomatostatinemia resulting from leakage into the peripheral circulation has effects on growth hormone secretion and glucoregulation.
    Tannenbaum GS; Patel YC
    Endocrinology; 1986 May; 118(5):2137-43. PubMed ID: 2870913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological profile of FK480, a novel cholecystokinin type-A receptor antagonist: comparison to loxiglumide.
    Ito H; Sogabe H; Nakarai T; Sato Y; Tomoi M; Kadowaki M; Matsuo M; Tokoro K; Yoshida K
    J Pharmacol Exp Ther; 1994 Feb; 268(2):571-5. PubMed ID: 7509389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.